|
|
Identification |
|
Name |
|
Rogaratinib |
|
Synonyms |
|
4-[[4-amino-6-(methoxymethyl)-5-(7-methoxy-5-methyl-1-benzothiophen-2-yl)pyrrolo[2,1-f][1,2,4]triazin-7-yl]methyl]piperazin-2-one |
|
|
Molecular Structure |
|
![CAS # 1443530-05-9, Rogaratinib, 4-[[4-amino-6-(methoxymethyl)-5-(7-methoxy-5-methyl-1-benzothiophen-2-yl)pyrrolo[2,1-f][1,2,4]triazin-7-yl]methyl]piperazin-2-one](/structures/1443530-05-9.gif) |
|
|
Molecular Weight |
|
466.56 |
|
CAS Registry Number |
|
1443530-05-9 |
|
EINECS |
|
948-594-9 |
|
SMILES |
|
CC1=CC2=C(C(=C1)OC)SC(=C2)C3=C4C(=NC=NN4C(=C3COC)CN5CCNC(=O)C5)N |
| |
|
Properties |
|
|
Density |
|
1.5±0.1 g/cm3, Calc.* |
|
Index of Refraction |
|
1.731, Calc.* |
| |
|
|
|
*
|
Calculated using Advanced Chemistry Development (ACD/Labs) Software.
|
|
| |
|
|
|
Safety Data |
|
|
Hazard Symbols |
|
GHS07 Warning Details |
|
Hazard Statements |
|
H302-H315-H319-H335 Details |
|
Precautionary Statements |
|
P261-P280-P301+P312-P302+P352-P305+P351+P338 Details |
|
SDS |
|
Available |
| |
|
|
| Market Analysis Reports |
|
|
|
| |
|
|
|
|
